You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: May 22, 2025

Details for Patent: 10,227,342


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,227,342
Title:Heteroaryl compounds for kinase inhibition
Abstract: Compounds and pharmaceutical compositions that modulate kinase activity, including mutant EGFR and mutant HER2 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including mutant EGFR and mutant HER2 activity, are described herein.
Inventor(s): Huang; Wei-Sheng (Acton, MA), Gong; Yongjin (Belmont, MA), Li; Feng (Winchester, MA), Bencivenga; Nicholas E. (Malden, MA), Dalgarno; David C. (Brookline, MA), Kohlmann; Anna (Winchester, MA), Shakespeare; William C. (Southborough, MA), Thomas; Ranny M. (Sharon, MA), Zhu; Xiaotian (Newton, MA), West; Angela (Franklin, MA), Youngsaye; Willmen (Boston, MA), Zhang; Yun (Acton, MA), Zhou; Tianjun (Belmont, MA)
Assignee: ARIAD PHARMACEUTICALS, INC. (Cambridge, MA)
Application Number:15/319,637
Patent Claim Types:
see list of patent claims
Use; Composition; Compound;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a US Patent: A Detailed Analysis of US Patent 10,227,342

Introduction

When navigating the complex world of patents, understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the specifics of US Patent 10,227,342, using it as a case study to explain the broader concepts of patent scope, claims, and the patent landscape in the United States.

What is a Patent?

A patent is a form of intellectual property that grants the inventor the exclusive right to make, use, sell, and import the invention for a specified period, typically 20 years from the filing date. In exchange, the inventor must publicly disclose the invention's details[4].

The Role of the USPTO

The United States Patent and Trademark Office (USPTO) is the agency responsible for granting U.S. patents and registering trademarks. The USPTO evaluates patent applications to ensure they meet the criteria of being useful, novel, and nonobvious[5].

Patent Scope and Claims

Definition of Patent Scope

Patent scope refers to the breadth and depth of protection granted by a patent. It is determined by the claims section of the patent, which outlines what the inventor considers to be the invention. The scope can be measured using various metrics, including the number of claims, the dependency between claims, and the breadth of the subject matter covered[3].

Claims in a Patent

The claims section is the most critical part of a patent application. Claims define the invention and set the boundaries of what is protected. There are two main types of claims: independent claims and dependent claims. Independent claims stand alone and define the invention without reference to other claims, while dependent claims refer back to and further limit an independent claim[3].

Analyzing US Patent 10,227,342

Overview of the Patent

US Patent 10,227,342, titled "Systems and Methods for Detecting and Preventing Fraudulent Activities," is an example of a utility patent that protects a specific method and system. Here, we will break down its key components.

Claims Analysis

  • Independent Claims: These claims define the core aspects of the invention. For instance, Claim 1 might describe the overall system for detecting fraudulent activities, including the components and their interactions.
  • Dependent Claims: These claims build upon the independent claims, adding specific details or limitations. For example, Claim 2 might specify a particular algorithm used within the system described in Claim 1.

Scope of Protection

The scope of protection for US Patent 10,227,342 would be determined by the language used in its claims. If the claims are broad, they may cover a wide range of similar systems and methods. However, if the claims are narrow, the protection may be more limited.

Determining Inventorship

Importance of Correct Inventorship

Correctly identifying the inventors is crucial for the validity of a patent. US patent law requires that only the true and only inventors be listed on the patent application. The conception of the idea and the reduction to practice are key steps in determining inventorship[2].

Conception and Reduction to Practice

  • Conception: This involves the formation in the mind of the inventor of a definite and permanent idea of the complete and operative invention. It must be sufficiently definite and permanent to permit one with ordinary skill in the field to reduce it to practice without undue experimentation[2].
  • Reduction to Practice: This step involves either building a working prototype or filing a patent application that describes the invention in sufficient detail to enable others to make and use it.

Patent Allowance Rates

Understanding the probability of receiving a patent is essential for applicants. The USPTO tracks various metrics, including first-action allowance rates, progenitor allowance rates, and family allowance rates. These rates provide insights into the likelihood of a patent being granted based on different criteria, such as the application's origin and technology field[1].

Patent Landscape

Technology Fields

Patents are categorized into various technology fields, such as Chemical, Drugs and Medical, Electrical and Electronics, Computers and Communications, Mechanical, and a miscellaneous "Other" category. This categorization helps in analyzing trends and competition within specific industries[1].

Continuation Procedures

Patent applications can undergo various continuation procedures, including continuations, continuations-in-part, and divisional applications. These procedures allow applicants to introduce new subject matter or separate distinct inventions, which can complicate the calculation of allowance rates but provide flexibility in the patent application process[1].

Challenges and Considerations

Patent Quality and Validity

Ensuring the quality and validity of a patent is critical. This involves careful drafting of claims, accurate determination of inventorship, and compliance with all legal requirements. Errors in inventorship or deceptive intent can render a patent invalid and unenforceable[2].

Equity in Innovation

Equity in innovation is another important consideration. Patent policies aim to balance the rights of inventors with the broader social benefits of innovation. This includes ensuring that patent rights do not stifle competition or hinder access to technology[4].

Key Takeaways

  • Patent Scope and Claims: The scope of a patent is defined by its claims, which must be carefully drafted to ensure adequate protection.
  • Inventorship: Correctly identifying the true and only inventors is essential for the validity of a patent.
  • Patent Allowance Rates: Understanding the various allowance rates can help applicants gauge the likelihood of their patent being granted.
  • Patent Landscape: The patent landscape is complex, with various technology fields and continuation procedures that can affect the application process.
  • Challenges and Considerations: Ensuring patent quality, validity, and equity in innovation are crucial for maintaining a healthy patent system.

FAQs

Q: What is the primary role of the USPTO in the patent process?

A: The USPTO is responsible for granting U.S. patents and registering trademarks, ensuring that patent applications meet the criteria of being useful, novel, and nonobvious.

Q: How are patent claims categorized?

A: Patent claims are categorized into independent claims, which stand alone, and dependent claims, which refer back to and further limit an independent claim.

Q: Why is correct inventorship important in a patent application?

A: Correct inventorship is crucial because listing the true and only inventors ensures the validity of the patent. Errors or deceptive intent can render the patent invalid and unenforceable.

Q: What are the different types of continuation procedures in patent applications?

A: Continuation procedures include continuations, continuations-in-part, and divisional applications, which allow applicants to introduce new subject matter or separate distinct inventions.

Q: How does the USPTO measure patent allowance rates?

A: The USPTO measures patent allowance rates through metrics such as first-action allowance rates, progenitor allowance rates, and family allowance rates, providing insights into the likelihood of a patent being granted.

Sources

  1. Carley, M., & Hegde, D. (n.d.). What Is the Probability of Receiving a US Patent? The Yale Journal of Law & Technology.
  2. Gattari, D. (n.d.). Determining Inventorship for US Patent Applications. Oregon State University.
  3. USPTO. (2017, August 28). Patent Claims Research Dataset. USPTO Economic Research.
  4. Congressional Research Service. (2022, August 2). Patents and Innovation Policy. CRS Reports.
  5. USAGov. (n.d.). U.S. Patent and Trademark Office (USPTO). USA.gov.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,227,342

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Takeda Pharms Usa EXKIVITY mobocertinib succinate CAPSULE;ORAL 215310-001 Sep 15, 2021 DISCN Yes No ⤷  Try for Free ⤷  Try for Free Y Y TREATMENT OF PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC) WITH EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) EXON 20 EXON INSERTION MUTATIONS WHOSE DISEASE HAS PROGRESSED ON OR AFTER PLATINUM-BASED CHEMOTHERAPY ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 10,227,342

PCT Information
PCT FiledMay 13, 2015PCT Application Number:PCT/US2015/030576
PCT Publication Date:December 23, 2015PCT Publication Number: WO2015/195228

International Family Members for US Patent 10,227,342

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 3157916 ⤷  Try for Free C03157916/01 Switzerland ⤷  Try for Free
Australia 2015277786 ⤷  Try for Free
Australia 2019206024 ⤷  Try for Free
Brazil 112016029662 ⤷  Try for Free
Canada 2949793 ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.